Related Experiment Video
Updated: Aug 10, 2025
08:27
Muscle Velocity Recovery Cycles to Examine Muscle Membrane Properties
Published on: February 19, 2020
14.2K
Osteomalacic myopathy: A re-emerging scourge hiding in plain sight
1Assistant Professor, Department of Neurology, 78595Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Tropical Doctor
|February 10, 2023
Summary
A study identified osteomalacic myopathy in children post-COVID-19, potentially linked to home confinement. This vitamin D deficiency is treatable and reversible.
Area of Science:
- Pediatric Neurology
- Metabolic Bone Disease
Background:
- Osteomalacic myopathy is a rare neuromuscular disorder characterized by bone softening.
- The COVID-19 pandemic led to unprecedented periods of home confinement globally.
- Limited sunlight exposure and dietary changes during confinement may impact vitamin D levels.
Purpose of the Study:
- To report a cluster of osteomalacic myopathy cases in children following the COVID-19 pandemic.
- To explore the potential role of pandemic-related home confinement in the observed increase of this condition.
Main Methods:
- Retrospective case series analysis.
- Clinical and biochemical evaluation of pediatric patients presenting with myopathic symptoms.
Main Results:
- A group of children were diagnosed with osteomalacic myopathy.
- The onset of symptoms coincided with the period of prolonged home confinement.
- Biochemical markers indicated vitamin D deficiency.
Conclusions:
- Home confinement during the COVID-19 pandemic may be associated with a resurgence of osteomalacic myopathy in children.
- Osteomalacic myopathy is a reversible condition with appropriate treatment.
- Increased awareness and proactive screening are recommended for at-risk populations.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
1.2K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.2K
01:20Myasthenia Gravis: Overview and Treatment
1.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.7K
01:28Disorders of the Skeletal Muscle
1.0K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.0K
01:21Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
01:24Muscle Recovery and Fatigue
2.2K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.2K
01:26Chemical Synapses
8.9K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.9K